Crossref
Formulation and Evaluation of Nanoparticles Containing Antiviral Protease Inhibitor
Mathews Journal of Pharmaceutical Science · 2023
DOI: 10.30654/mjps.10016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mathews Journal of Pharmaceutical Science, 2023. Verfasst von Harish Joshi und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Joshi, H., Bundela, R., Jain, S., & Shukla, K. (2023). Formulation and Evaluation of Nanoparticles Containing Antiviral Protease Inhibitor. Mathews Journal of Pharmaceutical Science. https://doi.org/10.30654/mjps.10016
Vancouver
Joshi H, Bundela R, Jain S, Shukla K. Formulation and Evaluation of Nanoparticles Containing Antiviral Protease Inhibitor. Mathews Journal of Pharmaceutical Science. 2023. doi:10.30654/mjps.10016
BibTeX
@article{Joshi2023,
author = {Joshi, Harish and Bundela, Ragini and Jain, Sourabh and Shukla, Karunakar},
title = {Formulation and Evaluation of Nanoparticles Containing Antiviral Protease Inhibitor},
journal = {Mathews Journal of Pharmaceutical Science},
year = {2023},
doi = {10.30654/mjps.10016}
}
EUVIMED